Bora CDMO Bora CDMO

X

CAS 66315-15-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
4CH-017062
Also known as: 66315-15-9, 3-amino-4-methylaminobenzoic acid, 3-amino-4-methylamino-benzoic acid, Schembl1067119, Dtxsid40467951, 3-amino-4-(methylamino)benzoicacid
Molecular Formula
C8H10N2O2
Molecular Weight
166.18  g/mol
InChI Key
QZZIBMYRWBVKLM-UHFFFAOYSA-N

1 2D Structure

4CH-017062

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-amino-4-(methylamino)benzoic acid
2.1.2 InChI
InChI=1S/C8H10N2O2/c1-10-7-3-2-5(8(11)12)4-6(7)9/h2-4,10H,9H2,1H3,(H,11,12)
2.1.3 InChI Key
QZZIBMYRWBVKLM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CNC1=C(C=C(C=C1)C(=O)O)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 66315-15-9

2. 3-amino-4-methylaminobenzoic Acid

3. 3-amino-4-methylamino-benzoic Acid

4. Schembl1067119

5. Dtxsid40467951

6. 3-amino-4-(methylamino)benzoicacid

7. Mfcd06208249

8. Zinc21993990

9. 3-amino-4-(methylamino) Benzoic Acid

10. Akos010216217

11. Benzoicacid,3-amino-4-(methylamino)-

12. Cs-w006930

13. Ds-12822

14. Ft-0646452

15. C76085

16. A835417

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 166.18 g/mol
Molecular Formula C8H10N2O2
XLogP30.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass166.074227566 g/mol
Monoisotopic Mass166.074227566 g/mol
Topological Polar Surface Area75.4 Ų
Heavy Atom Count12
Formal Charge0
Complexity172
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag South Korea
Digital Content Digital Content
URL Supplier Web Content
1046806-03-4
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% e...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY